estriol has been researched along with Atypical Endometrial Hyperplasia in 13 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Atypical Endometrial Hyperplasia: A benign form of endometrial hyperplasia with increased number of cells with atypia. The atypical cells are large and irregular and have an increased nuclear/cytoplasmic ratio. The risk of progression to endometrial carcinoma rises with the increasing degree of cell atypia.
Excerpt | Relevance | Reference |
---|---|---|
"No one atypical endometrial hyperplasia and endometrial intraepithelial neoplasia case during the study period was found." | 3.11 | Genitourinary syndrome, local oestrogen therapy and endometrial pathology: a single-centre, randomised study. ( Kovachev, MS; Kovachev, SM, 2022) |
" The incidences of adverse events were similar in all groups." | 2.69 | Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women. ( Gräser, T; Koytchev, R; Müller, A; Oettel, M, 2000) |
"Investigation of the effects of OCs on neoplasia is not easy; currently 4 investigative methods are used: 1) case reports, 2) disease rate and trends, 3) case-control studies, which are the main source of careful retrospective information, and 4) cohort studies, which compare the incidence of disease in patients exposed to suspected environmental factors, and in those who are not exposed." | 2.36 | Neoplasia and hormonal contraception. ( Huggins, GR, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (53.85) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Kovachev, SM | 1 |
Kovachev, MS | 1 |
Goldzieher, JW | 1 |
Fariss, B | 1 |
Huggins, GR | 2 |
Klemi, PJ | 1 |
Grönroos, M | 1 |
Rauramo, L | 1 |
Punnonen, R | 1 |
Niwa, K | 1 |
Murase, T | 1 |
Furui, T | 1 |
Morishita, S | 1 |
Mori, H | 2 |
Tanaka, T | 1 |
Tamaya, T | 1 |
Melis, GB | 1 |
Cagnacci, A | 1 |
Bruni, V | 1 |
Falsetti, L | 1 |
Jasonni, VM | 1 |
Nappi, C | 1 |
Polatti, F | 1 |
Volpe, A | 1 |
Weiderpass, E | 1 |
Baron, JA | 1 |
Adami, HO | 1 |
Magnusson, C | 1 |
Lindgren, A | 1 |
Bergström, R | 1 |
Correia, N | 1 |
Persson, I | 1 |
Dören, M | 1 |
Rübig, A | 1 |
Coelingh Bennink, HJ | 1 |
Holzgreve, W | 1 |
Gräser, T | 1 |
Koytchev, R | 1 |
Müller, A | 1 |
Oettel, M | 1 |
Myhre, E | 1 |
Giuntoli, RL | 1 |
Teter, J | 1 |
Wasilewska, B | 1 |
Whitehead, MI | 1 |
2 reviews available for estriol and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
Neoplasia and hormonal contraception.
Topics: Animals; Breast Diseases; Breast Neoplasms; Choriocarcinoma; Contraceptives, Oral; Contraceptives, O | 1981 |
Oral contraceptives and neoplasia.
Topics: Adolescent; Adult; Breast Neoplasms; Choriocarcinoma; Chronic Disease; Contraceptives, Oral; Contrac | 1979 |
3 trials available for estriol and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
Genitourinary syndrome, local oestrogen therapy and endometrial pathology: a single-centre, randomised study.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estriol; Estrogen Replacement Therapy; | 2022 |
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonograp | 1999 |
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometriu | 2000 |
8 other studies available for estriol and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen.
Topics: 17-Ketosteroids; Adrenal Glands; Adult; Androgens; Chromatography; Cysts; Endometrial Hyperplasia; E | 1967 |
Ultrastructural features of endometrial atypical adenomatous hyperplasia and adenocarcinomas and the plasma level of estrogens.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endometrial Hyperplasia; Estradiol; Estriol; Estroge | 1980 |
Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
Topics: Adenocarcinoma; Animals; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estriol; Estrone | 1993 |
Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
Topics: Absorptiometry, Photon; Administration, Intranasal; Administration, Intravaginal; Alkaline Phosphata | 1996 |
Low-potency oestrogen and risk of endometrial cancer: a case-control study.
Topics: Administration, Intravaginal; Administration, Oral; Aged; Case-Control Studies; Endometrial Hyperpla | 1999 |
Endometrial response to different estrogens.
Topics: Endometrial Hyperplasia; Endometrium; Estradiol; Estradiol Congeners; Estriol; Estrogens; Estrogens, | 1977 |
[Antiproliferative effect of estriol in endometrial hyperplasia].
Topics: Aged; Cell Division; Endometrial Hyperplasia; Estradiol Congeners; Estriol; Female; Humans; Middle A | 1979 |
Prevention of endometrial abnormalities.
Topics: Endometrial Hyperplasia; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female | 1986 |